IBT
KZR

International Biotechnology Trust’s Kezar Life Sciences KZR Stock Holding History

International Biotechnology Trust’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$831K Buy
+70,383
New +$1.25M 0.28% 54

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

International Biotechnology Trust's KZR Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in Kezar Life Sciences (KZR) in Q3 2023: 70,383 shares worth $831K. The stake represents 0.28% of the portfolio and ranks #54 among its holdings.

82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • International Biotechnology Trust held 70,383 shares of Kezar Life Sciences worth $831K as of Q3 2023.
  • Kezar Life Sciences was a new International Biotechnology Trust position in Q3 2023.
  • Kezar Life Sciences made up 0.28% of International Biotechnology Trust's portfolio in Q3 2023, its #54 holding.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.